First Time Loading...

Soligenix Inc
NASDAQ:SNGX

Watchlist Manager
Soligenix Inc Logo
Soligenix Inc
NASDAQ:SNGX
Watchlist
Price: 0.42045 USD 2.1%
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

SNGX Price Targets Summary
Soligenix Inc

Wall Street analysts forecast SNGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNGX is 3.4425 USD with a low forecast of 3.03 USD and a high forecast of 3.9375 USD.

SNGX Lowest Forecast
Wall Street Target
3.03 USD
621% Upside
SNGX Average Forecast
Wall Street Target
3.4425 USD
719% Upside
SNGX Highest Forecast
Wall Street Target
3.9375 USD
836% Upside
Lowest
Price Target
3.03 USD
621% Upside
Average
Price Target
3.4425 USD
719% Upside
Highest
Price Target
3.9375 USD
836% Upside
Soligenix Inc Competitors:
Price Targets
CRIS
Curis Inc
35% Upside
IONS
Ionis Pharmaceuticals Inc
36% Upside
PBYI
Puma Biotechnology Inc
4% Downside
APLT
Applied Therapeutics Inc
147% Upside
CRIS
Curis Inc
35% Upside
IONS
Ionis Pharmaceuticals Inc
36% Upside
PBYI
Puma Biotechnology Inc
4% Downside
APLT
Applied Therapeutics Inc
147% Upside
M
MGX
Metagenomi Inc
255% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
32% Upside
ICCC
ImmuCell Corp
175% Upside
3164
GenMont Biotech Inc
349% Upside

Revenue
Forecast

Revenue Estimate
Soligenix Inc

For the last 8 years the compound annual growth rate for Soligenix Inc's revenue is -25%. The projected CAGR for the next 3 years is 7%.

-25%
Past Growth
7%
Estimated Growth
Estimates Accuracy
10%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Soligenix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Soligenix Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-84%
Average Miss
What are analyst estimates?

See Also

Summary
SNGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
SNGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SNGX stock valuation using valuation multiples.
Wall Street Estimates
SNGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SNGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNGX's stock price target?
Price Target
3.4425 USD

According to Wall Street analysts, the average 1-year price target for SNGX is 3.4425 USD with a low forecast of 3.03 USD and a high forecast of 3.9375 USD.

What is Soligenix Inc's Revenue forecast?
Projected CAGR
7%

For the last 8 years the compound annual growth rate for Soligenix Inc's revenue is -25%. The projected CAGR for the next 3 years is 7%.

ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.